8-K//Current report
CASI Pharmaceuticals, Inc. 8-K
Accession 0001104659-22-090027
CIK 0000895051operating
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:01 PM ET
Size
357.4 KB
Accession
0001104659-22-090027
Documents
- 8-Ktm2222158d1_8k.htmPrimary
FORM 8-K
- EX-99.1tm2222158d1_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHcasi-20220812.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABcasi-20220812_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREcasi-20220812_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICtm2222158d1_ex99-1img001.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLtm2222158d1_8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-22-090027-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
CASI Pharmaceuticals, Inc (DE)
CIK 0000895051
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000895051
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:01 PM ET
- Size
- 357.4 KB